{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:13:08Z","timestamp":1715386388314},"reference-count":22,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2023,3,31]]},"DOI":"10.1536\/ihj.22-470","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T22:09:34Z","timestamp":1675116574000},"page":"109-113","source":"Crossref","is-referenced-by-count":0,"title":["Importance of Awareness and Careful Follow-Up of Suspected IgG4-Related Periaortitis"],"prefix":"10.1536","volume":"64","author":[{"given":"Fumiaki","family":"Nakashima","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Takagi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Hypertension and Heart Failure Center, Takagi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Tomiyoshi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Takagi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Ejima","sequence":"additional","affiliation":[{"name":"Department of Urology, Takagi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takateru","family":"Ootsuka","sequence":"additional","affiliation":[{"name":"Department of Radiology, Takagi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Nojiri","sequence":"additional","affiliation":[{"name":"Department of Radiology, Takagi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"International University of Health and Welfare Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Hirooka","sequence":"additional","affiliation":[{"name":"Hypertension and Heart Failure Center, Takagi Hospital"},{"name":"International University of Health and Welfare Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mizushima I, Kasashima S, Fujinaga Y, Kawano M, Ishizaka N. IgG4-related periaortitis\/periarteritis: an under-recognized condition that is potentially life-threatening. Mod Rheumatol 2019; 29: 240-50.","DOI":"10.1080\/14397595.2018.1546367"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mizushima I, Kasashima S, Fujinaga Y, <i>et al<\/i>. Clinical and pathological characteristics of IgG4-related periaortitis\/periarteritis and retroperitoneal fibrosis diagnosed based on experts&apos; diagnosis. Ann Vasc Dis 2019; 12: 460-72.","DOI":"10.3400\/avd.oa.19-00085"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Perugino CA, Wallace ZS, Meyersohn N, Oliveira G, Stone JR, Stone JH. Large vessel involvement by IgG4-related disease. Medicine 2016; 95: 28.","DOI":"10.1097\/MD.0000000000003344"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Maritati F, Rocco R, Buttini EA, <i>et al<\/i>. Clinical and prognostic significance of serum IgG4 in chronic periaortitis. An analysis of 113 patients. Front Immunol 2019; 10: 693.","DOI":"10.3389\/fimmu.2019.00693"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Peng L, Zhang P, Li J, <i>et al<\/i>. IgG4-related aortitis\/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease. Arthritis Res Ther 2020; 22: 103.","DOI":"10.1186\/s13075-020-02197-w"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ozawa M, Fujinaga Y, Asano J, <i>et al<\/i>. Clinical features of IgG4-related periaortitis\/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study. Ann Res Ther 2017; 19: 223.","DOI":"10.1186\/s13075-017-1432-8"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Inoue D, Zen Y, Abo H, <i>et al<\/i>. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology 2011; 261: 625-33.","DOI":"10.1148\/radiol.11102250"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Inoue D, Yoshida K, Yoneda N, <i>et al<\/i>. IgG4-related disease: dataset of 235 consecutive patients. Medicine 2015; 94: e680.","DOI":"10.1097\/MD.0000000000000680"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kawano M, Saeki T, Nakashima H. IgG4-related kidney disease and retroperitoneal fibrosis: an update. Mod Rheumatol 2019; 29: 231-9.","DOI":"10.1080\/14397595.2018.1554321"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ishizaka N, Fujinaga Y, Hourai R, Fujisawa T, Sohmiya K. Serum IgG4 levels in cardiovascular patients by comprehensive measurement. Ann Vasc Dis 2018; 11: 496-502.","DOI":"10.3400\/avd.oa.18-00103"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Umehara H, Okazaki K, Kawa S, <i>et al<\/i>. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4RD. Mod Rheumatol 2021; 31: 529-33.","DOI":"10.1080\/14397595.2020.1859710"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wallace ZS, Naden RP, Chari S, <i>et al<\/i>. The 2019 American College of Rheumatology\/European League against rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 2019; 79: 77-87.","DOI":"10.1136\/annrheumdis-2019-216561"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kasashima F, Kawakami K, Matsumoto Y, Endo M, Kasashima S, Kawashima A. IgG4-related arterial disease. Ann Vasc Dis 2018; 11: 72-7.","DOI":"10.3400\/avd.ra.18-00012"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. van Bommel EF, Siemes C, Hak LE, van deer Veer SJ, Hendriksz TR. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 2007; 49: 615-25.","DOI":"10.1053\/j.ajkd.2007.02.268"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mizushima I, Inoue D, Yamamoto M, <i>et al<\/i>. Clinical course after corticosteroid therapy in IgG4-related aortitis\/periaortitis and periarteritis: a retrospective multicenter study. Arthritis Res Ther 2014; 16: R156.","DOI":"10.1186\/ar4671"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cormley S, Bravo PT, Kos X, Solanki K, Khashram M. A case of IgG4-related retroperitoneal fibrosis with significant involvement of the abdominal aorta- a clinical and diagnostic challenge. J Vas Surg Cases Innov Tech 2022; 8: 275-80.","DOI":"10.1016\/j.jvscit.2022.02.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mukai S, Sakamoto N, Kakinoki H, <i>et al<\/i>. Serum IgG4 concentration is a potential predictive biomarker in glucocorticoid treatment for idiopathic retroperitoneal fibrosis. J Clin Med 2022; 11: 3538.","DOI":"10.3390\/jcm11123538"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Almeqdadi M, Al-Dulami M, Perepletchikov A, Tomera K, Jaber BL. Rituximab for retroperitoneal fibrosis due to IgG4-related disease: a case report and literature review. Clin Nephrol Case Studies 2018; 6: 4-10.","DOI":"10.5414\/CNCS109321"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yamada K, Yamamoto M, Saeki T, <i>et al<\/i>. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther 2017; 19: 262.","DOI":"10.1186\/s13075-017-1467-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ebe H, Tsuboi H, Hagiya C, <i>et al<\/i>. Clinical features of patients with IgG4-related disease complicated with perivascular lesions. Mod Rheumatol 2015; 35: 105-9.","DOI":"10.3109\/14397595.2014.903596"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sheth R, Malik D. Bilateral hydronephrosis from retroperitoneal fibrosis. Cureus 2020; 12: e12147.","DOI":"10.7759\/cureus.12147"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tanaka T, Masumori N. Current approach to diagnosis and management of retroperitoneal fibrosis. Int J Urol 2020; 27: 387-94.","DOI":"10.1111\/iju.14218"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/1\/64_22-470\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:05:29Z","timestamp":1715317529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/1\/64_22-470\/_article"}},"subtitle":["A Case of Spreading Retroperitoneal Fibrosis Effectively Treated with Steroid Therapy"],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.22-470","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"article-number":"22-470"}}